Furthermore, S100A14 associates with the clinical outcome of breast cancer patients (54) as it significantly correlates with lymph node metastasis (78) and reduced OS (69, 78) especially in the luminal B subtype (69). The gene discussed is S100A14; the disease is breast carcinoma.